The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Nonproteolytic Activation of Prorenin Contributes to Development of Cardiac Fibrosis in Genetic Hypertension
Open accessAbstract
In contrast to proteolytic activation of inactive prorenin by cleavage of the N-terminal 43 residue peptide, we found that prorenin is activated without proteolysis by binding of the prorenin receptor to the pentameric “handle region” I 11P LLKK 15P . We hypothesized that such activation occurs in hypertensive rats and causes cardiac renin–angiotensin system (RAS) activation and end-organ damage. To test this hypothesis, we devised methods of specifically inhibiting nonproteolytic activation by decapeptide spanning the pentameric handle region peptide as a decoy. In stroke-prone spontaneously hypertensive rats (SHRsp) fed a high-salt diet, arterial pressure started to rise significantly with a marked increase in the cardiac prorenin receptor mRNA level at 8 weeks of age, and cardiac fibrosis had developed by 12 weeks of age. By immunohistochemistry using antibodies to the active site of the renin molecule, we demonstrated increased proteolytic or nonproteolytic activation of prorenin in the heart but not in plasma of SHRsp. Continuous subcutaneous administration of the handle region peptide completely inhibited the increased staining by antibodies to the active site of the renin molecule, indicating the increased nonproteolytic but not proteolytic activation of prorenin in the heart of SHRsp. Administration of the handle region peptide also inactivated tissue RAS without affecting circulating RAS or arterial pressure and significantly attenuated the development and progression of cardiac fibrosis. These results clearly demonstrate the significant role of nonproteolytically activated tissue prorenin in tissue RAS activation leading to cardiac fibrosis and significant inhibition of the cardiac damage produced by chronic infusion of the handle region peptide.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hansson, L., Zanchetti, A., Carruthers, S. G., Dahlöf, B., Elmfeldt, D., Julius, S., Ménard, J., Rahn, K. H., Wedel, H., & Westerling, S. (1998) · The Lancet · doi:10.1016/s0140-6736(98)04311-6 · Cited by 5,728
Adler, A. I. (2000) · BMJ · doi:10.1136/bmj.321.7258.412 · Cited by 2,133
Nguyen, G., Delarue, F., Burcklé, C., Bouzhir-Sima, L., Giller, T., & Sraer, J. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14276 · Cited by 1,276
Nguyen, G., Delarue, F., Burcklé, C., Bouzhir, L., Giller, T., & Sraer, J.-D. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214276 · Cited by 1,137
Ichihara, A., Hayashi, M., Kaneshiro, Y., Suzuki, F., Nakagawa, T., Tada, Y., Koura, Y., Nishiyama, A., Okada, H., Uddin, M. N., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421398 · Cited by 456
Self-citationHuman Prorenin Has “Gate and Handle” Regions for Its Non-proteolytic Activation
Suzuki, F., Hayakawa, M., Nakagawa, T., Nasir, U. M., Ebihara, A., Iwasawa, A., Ishida, Y., Nakamura, Y., & Murakami, K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302579200 · Cited by 185
Self-citationEffect of angiotensin II type 1 receptor blockade on experimental hepatic fibrogenesis
Paizis, G., Gilbert, R. E., Cooper, M. E., Murthi, P., Schembri, J. M., Wu, L. L., Rumble, J. R., Kelly, D. J., Tikellis, C., Cox, A. J., et al. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00146-5 · Cited by 157
Mannose 6-Phosphate Receptor–Mediated Internalization and Activation of Prorenin by Cardiac Cells
van Kesteren, C. A. M., Danser, A. H. J., Derkx, F. H. M., Dekkers, D. H. W., Lamers, J. M. J., Saxena, P. R., & Schalekamp, M. A. D. H. (1997) · Hypertension · doi:10.1161/01.hyp.30.6.1389 · Cited by 142
Functional Significance of Prorenin Internalization in the Rat Heart
Peters, J., Farrenkopf, R., Clausmeyer, S., Zimmer, J., Kantachuvesiri, S., Sharp, M. G. F., & Mullins, J. J. (2002) · Circulation Research · doi:10.1161/01.res.0000019242.51541.99 · Cited by 120
Maru, I., Ohta, Y., Murata, K., & Tsukada, Y. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.27.16294 · Cited by 114
Cited by
Kaneshiro, Y., Ichihara, A., Sakoda, M., Takemitsu, T., Nabi, A. H. M. N., Uddin, M. N., Nakagawa, T., Nishiyama, A., Suzuki, F., Inagami, T., et al. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006091062 · Cited by 256
Self-citationThe (pro)renin receptor in health and disease
Ichihara, A., & Yatabe, M. S. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0160-5 · Cited by 137
Self-citation(Pro)renin and its receptors: pathophysiological implications
Batenburg, W. W., & Danser, A. H. J. (2012) · Clinical Science · doi:10.1042/cs20120042 · Cited by 58
Liška, F., Landa, V., Zídek, V., Mlejnek, P., Šilhavý, J., Šimáková, M., Strnad, H., Trnovská, J., Škop, V., Kazdová, L., et al. (2017) · Hypertension · doi:10.1161/hypertensionaha.116.08798 · Cited by 42
Metadata
- Authors
- Ichihara, A., Kaneshiro, Y., Takemitsu, T., Sakoda, M., Suzuki, F., Nakagawa, T., Nishiyama, A., Inagami, T., & Hayashi, M.
- Venue
- Hypertension
- Published
- 2006-05
- Volume
- 47
- Issue
- 5
- Pages
- 894-900
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W2153396732
- Cited by
- 264
- References
- 17
- FWCI
- 24.50
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Nonproteolytic Activation of Prorenin Contributes to Development of Cardiac Fibrosis in Genetic Hypertension. https://app.cochat.ai/papers/10.1161/01.hyp.0000215838.48170.0b
- The paper
- Ichihara, A., Kaneshiro, Y., Takemitsu, T., Sakoda, M., Suzuki, F., Nakagawa, T., Nishiyama, A., Inagami, T., & Hayashi, M. (2006). Nonproteolytic Activation of Prorenin Contributes to Development of Cardiac Fibrosis in Genetic Hypertension. Hypertension. https://doi.org/10.1161/01.hyp.0000215838.48170.0b
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.